Skip to content

Press Releases


Filter Releases
 
Press Releases
Date Title and Summary View
Aug 15, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 15, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has scheduled an Investor Forum at the Congress of Neurological Surgeons meeting on Tuesday, October 2, 2001 at 7:30 AM Pacific Time at the Radisson Hotel Harbor View in San Diego, California. ...
Aug 13, 2001
PLAINSBORO, N.J., Aug 13, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has closed its public offering of 5,060,000 shares of common stock at $25.50 per share, including 660,000 shares for which the underwriters exercised their over-allotment option. Of the 5,060,000 shares, 4,747,5...
Aug 9, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 9, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has priced a public offering of 5,060,000 shares of common stock at $25.50 per share, including 660,000 shares for which the underwriters exercised their over-allotment option. Of the 5,060,000 shares, 4,747...
Aug 2, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 2, 2001-- Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $4.7 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues and net income for th...
Jul 23, 2001
PLAINSBORO, N.J., Jul 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has rescheduled its conference call to discuss financial results for the second quarter ended June 30, 2001 and to update forward looking guidance for the remainder of 2001 and the years 2002 and 2003. The conference...
Jul 20, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--July 20, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced that it had filed an amendment to its registration statement on Form S-3 with the Securities and Exchange Commission for a proposed underwritten offering of 3,750,000 shares of Integra common stock, plus an additi...
Jul 5, 2001
PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) --Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received 510(k) clearance from the FDA to market the NeuraGen™ Nerve Guide, an absorbable implant for the repair of severed peripheral nerves in the ex...
Jun 27, 2001
PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding for the development of tyrosine-derived polycarbonates. Funded by a three-year grant from the National Institute of Standards and Technology's Advanced Technology ...
Jun 8, 2001
PLAINSBORO, N.J., Jun 8, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Goldman Sachs 22nd Annual Healthcare Conference in Dana Point, California on Wednesday, June 13, 2001 beginning at 7:40 PM EST. The presentation will be delivered by Stuart Essig, P...
Jun 4, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--June 1, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission. When effective, the registration statement will permit Integra to offer and sell various type...
May 25, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--May 25, 2001--Integra NeuroSciences today announced that Linda Littlejohns, Vice President of Clinical Development, was the recipient of a Circle of Excellence Award from the American Association of Critical-Care Nurses (AACN). The AACN's awards program recognizes the contributions and ...
May 9, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--May 9, 2001--Led by strong growth in revenues, Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record net income and revenues for the first quarter of 2001. Earnings for the quarter were $0.07 per share, as compared to an adjusted net loss of $0.08 per share in ...
= add release to Briefcase